SCHEMBL20127381

SCHEMBL20127381

c1ccc2cc(-c3c4ccccc4c(-c4ccc5c(c4)oc4c6ccccc6c(-c6ccc7ccccc7c6)cc54)c4ccccc34)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 9/20 0.44
CYP1B1 Q16678 9/20 0.44
DYRK1A Q13627 1/20 0.41
GPR84 Q9NQS5 1/20 0.39
GSTP1 P09211 1/20 0.39
ALOX5 P09917 1/20 0.39
MIF P14174 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
PRKDC P78527 4/20 0.36
NOTUM Q6P988 1/20 0.35
CYP1A2 P05177 8/20 0.34
ABCB1 P08183 2/20 0.34
ABCC1 P33527 2/20 0.34
ABCG2 Q9UNQ0 2/20 0.34
KDM4E B2RXH2 1/20 0.34
PDE5A O76074 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127378 0.95 CYP1A1 (0.42) CYP1A1CYP1B1DYRK1AGPR84GSTP1
SCHEMBL20127379 0.93 CYP1A1 (0.41) CYP1A1CYP1B1DYRK1AGPR84GSTP1
SCHEMBL20127386 0.93 CYP1A1 (0.43) CYP1A1CYP1B1DYRK1AGPR84GSTP1
SCHEMBL10122494 0.93 ALOX5 (0.46) CYP1A1CYP1B1DYRK1AGPR84GSTP1
SCHEMBL20127380 0.93 ALOX5 (0.40) CYP1A1CYP1B1DYRK1AGPR84GSTP1
SCHEMBL19076509 0.92 ALOX5 (0.43) CYP1A1CYP1B1DYRK1AGPR84GSTP1
SCHEMBL10122648 0.92 ALOX5 (0.43) CYP1A1CYP1B1DYRK1AGPR84GSTP1
SCHEMBL19076503 0.91 ALOX5 (0.42) CYP1A1CYP1B1DYRK1AGPR84GSTP1
SCHEMBL16067698 0.90 CYP1A1 (0.54) CYP1A1CYP1B1DYRK1APRKDCCYP1A2
SCHEMBL20127383 0.90 CYP1A1 (0.40) CYP1A1CYP1B1DYRK1AGPR84ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 CYP1A1 399/4885CYP1B1 341/4885DYRK1A 3930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.